WallStreetZenWallStreetZen

NASDAQ: FUSN
Fusion Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for FUSN

Based on 8 analysts offering 12 month price targets for Fusion Pharmaceuticals Inc.
Min Forecast
$15.00-29.44%
Avg Forecast
$20.25-4.75%
Max Forecast
$24.00+12.89%

Should I buy or sell FUSN stock?

Based on 8 analysts offering ratings for Fusion Pharmaceuticals Inc.
Hold
Strong Buy
1 analysts 12.5%
Buy
1 analysts 12.5%
Hold
6 analysts 75%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their FUSN stock forecasts and price targets.

FUSN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-21
lockedlocked$00.00+00.00%2024-03-21
lockedlocked$00.00+00.00%2024-03-20
lockedlocked$00.00+00.00%2024-03-20
lockedlocked$00.00+00.00%2024-03-19
Leerink Partners
Bottom 28%
28
HoldDowngrades$21.00-1.22%2024-03-19
Raymond James
Top 12%
89
Strong BuyMaintains$16.00-24.74%2024-01-05Find out why
Oppenheimer
Top 10%
91
BuyMaintains$15.00-29.44%2024-01-05

1 of 1

Forecast return on equity

Is FUSN forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
36%

Forecast return on assets

Is FUSN forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

FUSN revenue forecast

What is FUSN's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$11.2M+441.59%
Avg 2 year Forecast
$1.0M-51.64%
Avg 3 year Forecast
$17.8M+758.46%
FUSN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

FUSN revenue growth forecast

How is FUSN forecast to perform vs Biotechnology companies and vs the US market?
Company
96.93%
Industry
38.03%
Market
10.06%
FUSN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
FUSN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

FUSN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
FUSN$21.26$20.25-4.75%Hold
RNA$22.73$44.50+95.78%Strong Buy
CPRX$15.13$27.40+81.10%Strong Buy
NAMS$19.93$33.25+66.83%Strong Buy
SNDX$20.80$34.67+66.67%Strong Buy
View Top Biotech Stocks

Fusion Pharmaceuticals Stock Forecast FAQ

Is Fusion Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: FUSN) stock is to Hold FUSN stock.

Out of 8 analysts, 1 (12.5%) are recommending FUSN as a Strong Buy, 1 (12.5%) are recommending FUSN as a Buy, 6 (75%) are recommending FUSN as a Hold, 0 (0%) are recommending FUSN as a Sell, and 0 (0%) are recommending FUSN as a Strong Sell.

If you're new to stock investing, here's how to buy Fusion Pharmaceuticals stock.

What is FUSN's revenue growth forecast for 2024-2026?

(NASDAQ: FUSN) Fusion Pharmaceuticals's forecast annual revenue growth rate of 96.93% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.03%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.06%.

Fusion Pharmaceuticals's revenue in 2024 is $2,068,000.On average, 4 Wall Street analysts forecast FUSN's revenue for 2024 to be $948,556,952, with the lowest FUSN revenue forecast at $59,284,810, and the highest FUSN revenue forecast at $3,387,703,400. On average, 1 Wall Street analysts forecast FUSN's revenue for 2025 to be $84,692,585, with the lowest FUSN revenue forecast at $84,692,585, and the highest FUSN revenue forecast at $84,692,585.

In 2026, FUSN is forecast to generate $1,503,547,462 in revenue, with the lowest revenue forecast at $84,692,585 and the highest revenue forecast at $4,171,956,737.

What is FUSN's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: FUSN) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is FUSN's Price Target?

According to 8 Wall Street analysts that have issued a 1 year FUSN price target, the average FUSN price target is $20.25, with the highest FUSN stock price forecast at $24.00 and the lowest FUSN stock price forecast at $15.00.

On average, Wall Street analysts predict that Fusion Pharmaceuticals's share price could fall to $20.25 by Mar 21, 2025. The average Fusion Pharmaceuticals stock price prediction forecasts a potential downside of 4.75% from the current FUSN share price of $21.26.

What is FUSN's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: FUSN) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.